An Open-Label Tolerability and Actual-Use Human Factors Study of Etrolizumab Autoinjector in Healthy Volunteers

Documenti analoghi

• Comparable Pharmacokinetics, Safety, and Tolerability of Etrolizumab Administered by Prefilled Syringe or Autoinjector in a Randomized Trial in Healthy Volunteers
  di: Zhang, Wenhui, et al.
  Pubblicazione: (2021)
• Etrolizumab for the Treatment of Ulcerative Colitis and Crohn’s Disease: An Overview of the Phase 3 Clinical Program
  di: Sandborn, William J., et al.
  Pubblicazione: (2020)
• Pharmacokinetic interactions and tolerability of rosuvastatin and ezetimibe: an open-label, randomized, multiple-dose, crossover study in healthy male volunteers
  di: Kim H, et al.
  Pubblicazione: (2018-04-01)
• Pharmacokinetic interactions and tolerability of rosuvastatin and ezetimibe: an open-label, randomized, multiple-dose, crossover study in healthy male volunteers
  di: Kim, Hyungsub, et al.
  Pubblicazione: (2018)
• Pharmacokinetics and tolerability of multiple-dose rosuvastatin: An open-label, randomized-sequence, three-way crossover trial in healthy Chinese volunteers
  di: Zhang, Ruoqi, et al.
  Pubblicazione: (2009)